Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

IXJvsPBPHETF Comparison

ETF 1
IXJ

iShares Global Healthcare ETF

This fund is part of
Global Large Cap
+2.36%
VS
ETF 2
PBPH

Portfolio Building Block World Pharma and Biotech Index ETF

This fund is part of
DM Large & Mid Cap
+2.01%

iShares Global Healthcare ETF (IXJ) belongs to the Global Large Cap segment. Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) is part of the DM Large & Mid Cap segment. IXJ's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Consumer Cyclicals. In contrast, PBPH's top sector exposures are Healthcare,  IXJ is more expensive with a Total Expense Ratio (TER) of 0.4%, versus 0.13% for PBPH. IXJ is up 4.9% year-to-date (YTD) with -$530M in YTD flows. PBPH performs better with 8.7% YTD performance, and +$933M in YTD flows. Run a side-by-side ETF comparison of IXJ and PBPH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

IXJ vs PBPH performance and flow charts

Performance

-2.0-1.00.01.02.03.04.0%Jun 30Jul 7Jul 14Jul 21Jul 28

Cumulative Flows

0 M50 M100 M150 M200 MJun 30Jul 7Jul 14Jul 21Jul 28

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/30/2026
1M3MYTD1Y3Y5Y
Perf.
IXJ
PBPH
+2.87%+1.04%
+9.83%+9.56%
+4.90%+8.70%
+20.30%n/a
+23.01%n/a
+26.12%n/a
Flows
IXJ
PBPH
+$175M+$103M
+$199M+$129M
-$530M+$933M
-$281M-
-$520M-
+$195M-
Volatility and drawdown
3M1Y3Y5Y
Volatility
IXJ
PBPH
+17.32%+18.27%
+15.40%n/a
+13.91%n/a
+14.35%n/a
Max drawdown
IXJ
PBPH
-3.91%-4.94%
-10.83%n/a
-18.04%n/a
-18.04%n/a
Max drawdown duration
IXJ
PBPH
22d20d
122dn/a
490dn/a
490dn/a
Trading data

Create an account to view trading data

Join for free
IXJ
PBPH
Last sale
7/31/2026 at 1:30 PM
$100.26
$27.19
Previous close
07/30/2026
$101.24
$27.53
Consolidated volume
07/30/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
IXJ
PBPH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/31/2026 at 1:30 PM
Live
Closed
IXJ
PBPH
Last price
$100.26
$27.19
1D performance
-0.97%
-1.24%
AuM$4.13 B$960.99 M
E/R0.4%0.13%
Characteristics
IXJ
PBPH
Management strategyPassivePassive
ProvideriSharesTidal
BenchmarkS&P Global 1200 Health Care (Sector) Capped IndexBITA Global Pharma and Biotech Select Index
N° of holdings11052
Asset class--
Trailing 12m distribution yield
Join
Join
Inception dateNovember 13, 2001November 24, 2025
ESGNoNo
Advertisement
Exposure

Countries

IXJ
USA
69.49%
Switzerland
10.37%
Other
20.14%
PBPH
USA
65.6%
Switzerland
10.39%
United Kingdom
7.56%
Other
16.46%

Sectors

IXJ
Healthcare
96.99%
Other
3.01%
PBPH
Healthcare
99.59%
Other
0.41%
Advertisement

Diversification

IXJ

Total weight of top 15 holdings out of 15

57.47%
PBPH

Total weight of top 15 holdings out of 15

75.88%

Top 15 holdings

Data as of June 30, 2026
IXJ
Eli Lilly & Co.
10.92%
Johnson & Johnson
7.04%
AbbVie, Inc.
5.12%
UnitedHealth Group, Inc.
4.39%
Merck & Co., Inc.
4.12%
AstraZeneca PLC
3.77%
Roche Holding AG
3.76%
Novartis AG
3.73%
Amgen, Inc.
2.54%
Thermo Fisher Scientific, Inc.
2.42%
Abbott Laboratories
2.05%
Gilead Sciences, Inc.
2.03%
Novo Nordisk A/S
1.99%
Intuitive Surgical, Inc.
1.83%
Pfizer Inc.
1.78%
PBPH
Eli Lilly & Co.
16.15%
Johnson & Johnson
9.67%
AbbVie, Inc.
6.99%
Merck & Co., Inc.
4.97%
Roche Holding AG
4.52%
Novartis AG
4.43%
AstraZeneca PLC
4.31%
Amgen, Inc.
4.30%
Gilead Sciences, Inc.
3.63%
Novo Nordisk A/S
3.55%
Pfizer Inc.
3.22%
Vertex Pharmaceuticals, Inc.
2.93%
Bristol Myers Squibb Co.
2.77%
GSK Plc
2.26%
Sanofi
2.17%
Frequently asked questions about IXJ and PBPH

How have the IXJ and PBPH ETFs performed in 2026?

As of July 30, 2026, IXJ is up 4.9% year-to-date (YTD), while PBPH has returned 8.7%. That puts PBPH better performer ahead so far this year.

Which ETF is attracting more investor money: IXJ or PBPH?

Year-to-date, the IXJ ETF saw -$530M in flows, compared to +$933M for PBPH.

Which ETF is bigger: IXJ or PBPH?

As of July 30, 2026, IXJ holds $4.13 B in assets under management (AUM), while PBPH manages $960.99 M.

What sectors do the IXJ and PBPH ETFs invest in?

IXJ leans toward sectors like Healthcare. Meanwhile, PBPH focuses on Healthcare.

What are the top holdings of the IXJ ETF and PBPH ETF?

IXJ top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. PBPH holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: IXJ or PBPH?

IXJ holds 111 securities with 57.47% of its assets in the top 15. PBPH has 53 securities and a top 15 weight of 75.88%.

Advertisement
Latest news about IXJ & PBPH
Advertisement
Advertisement
Advertisement
Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey and get exclusive early access to the final report.

Global ETF Survey 2026